Captor Therapeutics SA
60Q
Company Profile
Business description
Captor Therapeutics SA is a biopharmaceutical company. It is focused on development of protein degradation drugs for cancer and autoimmune diseases, which have limited or no known treatment options.
Contact
ul. Dunska 11
Wroclaw54-427
POLT: +48 537869089
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
91
Stocks News & Analysis
stocks
Cheap e-commerce share continues sales momentum
The e-commerce business continues its sales momentum despite challenging backdrop.
stocks
Chart of the Week: Booming mined commodity prices see little value on offer
Iran War disruptions drive thermal coal and aluminum prices higher but value to be found in other pockets.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,819.60 | 65.10 | -0.73% |
| CAC 40 | 8,188.87 | 19.02 | -0.23% |
| DAX 40 | 25,092.25 | 85.55 | -0.34% |
| Dow JONES (US) | 50,664.62 | 20.34 | 0.04% |
| FTSE 100 | 10,425.96 | 79.05 | -0.75% |
| HKSE | 25,006.16 | 322.07 | -1.27% |
| NASDAQ | 26,881.81 | 207.07 | 0.78% |
| Nikkei 225 | 64,693.12 | 306.29 | -0.47% |
| NZX 50 Index | 13,206.11 | 21.70 | -0.16% |
| S&P 500 | 7,560.85 | 40.49 | 0.54% |
| S&P/ASX 200 | 8,592.90 | 61.60 | -0.71% |
| SSE Composite Index | 4,098.64 | 4.91 | 0.12% |